New non-executive director appointments
Mark Duddridge will join the Trust’s board for an initial 3-year term from April 2022 as a non-executive director. Dean Harvey joins as an associate non-executive director for an initial 12-month term from May 2022.
Mark is an experienced director and non-executive director. He currently is chair of the Cornwall and Isles of Scilly LEP and Coastline Housing. He has previously held roles with Rodda’s and Samworth Brothers.
“I am delighted to be joining the Trust at a time when so much work is ongoing to create more integrated health services in Cornwall and the Scillies. The Trust faces many challenges as we emerge from COVID. I am looking forward to working with the new executive team on the changes the organisation will be making to deliver the best outcomes or both its patients and staff.” Mark Duddridge
Mark is joined by Dean Harvey, who is taking on the role of associate non-executive director. Dean is well known locally for his work with the award-winning Cornish charity, Pentreath where he’s a community development worker.
“I feel extremely proud to be offered this opportunity to build upon the good work of colleagues and networks. Especially in the areas of diversity and inclusion. The role offers a chance to amplify the voices of staff, patients, and communities to board level. My intention for this role will be to work with staff, patients and the wider community to respond to existing health inequalities. With the aim of building on our acknowledgement for the need of long-term equity-orientated organisational change.” Dean Harvey
Associate non-executive director roles bring additional skills and scrutiny to the Board of Directors. One of Dean’s main areas of focus will be to strengthen inclusion and diversity in the Trust.
“It is great news for the Board of Directors and the wider Trust that Dean and Mark are taking on these roles. I look forward to working with them. I know the wealth of experience, knowledge, and perspectives they bring will benefit the Trust and ultimately our patients.” Margaret Schwarz, Chair